用XI/XIa因子抑制剂预防和治疗静脉血栓栓塞:目前的状况和未来的前景
Raul Del Toro-Mijares1, Mateo Porres-Aguilar2, Laurent Bertoletti3
1Department of Internal Medicine, Texas Tech Health El Paso, El Paso, Texas, United States. radeltor@ttuhsc.edu.
Journal of thrombosis and thrombolysis
|July 8, 2025
概括
XI因子抑制剂在高风险患者预防血栓方面表现有前途,可能为降低出血风险的当前治疗提供更安全的替代方案. 为了广泛的临床使用,需要进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 血栓形成的研究研究
背景情况:
- 目前用于静脉血栓塞栓症 (VTE) 的治疗方法包括华法林,肝素和直接口服抗凝剂.
- 为高风险VTE患者寻找更安全的替代品,包括那些患有癌症,术后状态或末期脏疾病的患者.
- 因子XI与血栓形成有关,但对正常血液静止无关,因此它是抗凝剂的潜在点,降低了出血风险.
研究的目的:
- 评估XI因子抑制剂作为更安全的静脉血栓塞栓症抗凝剂的潜力.
- 评估XI因子抑制在特定高风险患者群体中的有效性和安全性.
- 确定XI因子抑制剂的未来研究和临床开发的关键领域.
主要方法:
- 对因子XI抑制剂最近的第二阶段临床试验的综述.
- 分析XI因子在血栓形成和血液静止中的作用.
- 鉴定VTE治疗和XI因子抑制剂开发的未满足需求.
主要成果:
- 第二阶段试验表明,XI因子抑制剂对接受全膝关节整形手术的患者,癌症患者和末期病患者的VTE预防具有前景.
- 抑制XI因子可以降低血栓形成风险,同时最大限度地减少出血并发症.
- XI因子抑制剂代表了对VTE的新治疗方法.
结论:
- XI因子抑制剂在各种高风险群体中显示出预防静脉瘤的巨大潜力.
- 需要进一步进行大规模的第三期试验,以确认疗效和安全性.
- 解决更广泛的外科应用和出血管理策略对于临床整合至关重要.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
01:30Venous Thrombosis IV: Nursing Management
25
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
25
01:27Pulmonary Embolism III: Nursing Management
44
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
44
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
46
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
46